Immunogenicity of the BNT162b2 mRNA Covid-19 vaccine in elderly people over 85 years of age in Greece: the GREVAXIMO study.

导出 OA

翻译打印收藏纠错

第一作者： Konstantina,Kontopoulou

第一单位： Laboratory of Microbiology, "G. Gennimatas" General Hospital, Thessaloniki, Greece.

作者： Konstantina,Kontopoulou ^[1] ; Christos Theodore,Nakas ^[2] ; Alexandra,Ainatzoglou ^[3] ; Athina,Ifantidou ^[1] ; Paschalina,Ntotsi ^[4] ; Christos,Katsioulis ^[4] ; Georgios,Papazisis ^[5]

作者单位： Laboratory of Microbiology, "G. Gennimatas" General Hospital, Thessaloniki, Greece. ^[1] Laboratory of Biometry, University of Thessaly, Phytokou Str, 38446, Nea Ionia, Magnesia, Greece.;University Institute of Clinical Chemistry, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. ^[2] Department of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. ^[3] Committee of Hospital Infections, "G. Gennimatas" General Hospital, Thessaloniki, Greece. ^[4] Department of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. papazisg@auth.gr.;Clinical Trials Unit, Special Unit for Biomedical Research and Education, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece. papazisg@auth.gr. ^[5]

关键词 Antibodies BNT162b2 mRNA Covid-19 vaccine Elderly over age 85 Greece Immunogenicity SARS-CoV-2

主题词老年人(Aged);希腊(Greece);人类(Humans);RNA, 信使(RNA, Messenger)

DOI 10.1007/s40520-021-01997-7

PMID 34633648

发布时间 2022-02-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交